m6A epitranscriptomic regulation of tissue homeostasis during primate aging

Nat Aging. 2023 Jun;3(6):705-721. doi: 10.1038/s43587-023-00393-2. Epub 2023 Apr 6.

Abstract

How N6-methyladenosine (m6A), the most abundant mRNA modification, contributes to primate tissue homeostasis and physiological aging remains elusive. Here, we characterize the m6A epitranscriptome across the liver, heart and skeletal muscle in young and old nonhuman primates. Our data reveal a positive correlation between m6A modifications and gene expression homeostasis across tissues as well as tissue-type-specific aging-associated m6A dynamics. Among these tissues, skeletal muscle is the most susceptible to m6A loss in aging and shows a reduction in the m6A methyltransferase METTL3. We further show that METTL3 deficiency in human pluripotent stem cell-derived myotubes leads to senescence and apoptosis, and identify NPNT as a key element downstream of METTL3 involved in myotube homeostasis, whose expression and m6A levels are both decreased in senescent myotubes. Our study provides a resource for elucidating m6A-mediated mechanisms of tissue aging and reveals a METTL3-m6A-NPNT axis counteracting aging-associated skeletal muscle degeneration.

MeSH terms

  • Aging / genetics
  • Animals
  • Homeostasis / genetics
  • Humans
  • Liver*
  • Methyltransferases / genetics
  • Primates* / genetics

Substances

  • METTL3 protein, human
  • Methyltransferases